Controversies in the Management of FLUTD and Urethral Obstruction in Cats

Feline lower urinary tract disease (FLUTD) and urethral obstruction (UO) remain among the most common—and sometimes most debated—emergencies encountered in small animal practice.
 

While the fundamentals of treatment, including stabilization, relief of the obstruction, pain management, and supportive care, are well established, several aspects of medical management continue to generate discussion within veterinary medicine.
 

Should NSAIDs be used? When are antibiotics actually indicated? And does prazosin really reduce the risk of recurrent obstruction?
 

As our understanding of FLUTD and UO continues to evolve, so should our approach to managing these patients.
 

NSAIDs: Helpful or an Unnecessary Risk?

Pain control is a cornerstone of treatment for cats with FLUTD and urethral obstruction. However, the role of nonsteroidal anti-inflammatory drugs (NSAIDs) in these patients is nuanced.

Cats presenting with urethral obstruction often have varying degrees of dehydration, electrolyte abnormalities, and renal compromise resulting in azotemia. Because NSAIDs can reduce renal perfusion, particularly in hypovolemic patients, their use during the acute phase is generally discouraged.

Instead, opioids such as buprenorphine or methadone are commonly prioritized during initial stabilization.

Once a patient is rehydrated, hemodynamically stable, and showing improvement in azotemia, some clinicians may consider short-term NSAID therapy to address inflammation and discomfort. However, available evidence has not demonstrated a clear clinical benefit.

One study comparing cats receiving meloxicam with those who did not found **no significant difference in recurrence rates, perceived comfort, or voiding behavior either in the hospital or at home.**³

Similarly, a review evaluating three randomized controlled trials and one retrospective cohort study found no significant association between the use of glucocorticoids or NSAIDs and either the severity of FLUTD clinical signs or the risk of reobstruction.

What Do We Do in Our Hospital?

Clinical opinions can vary, even within the same hospital.

The majority of our clinicians avoid NSAIDs in cats with urethral obstruction or FLUTD because of the potential for renal compromise. Even in cats that are not currently obstructed, the risk of a future obstruction is considered when weighing the potential benefits and risks of NSAID therapy.

When anti-inflammatory therapy is considered necessary, some clinicians may instead use an anti-inflammatory dose of corticosteroids, generally without sending the patient home on a prolonged steroid taper.

As with any treatment decision, therapy should be tailored to the individual patient and their clinical status.

Antibiotics: Moving Away From “Just in Case”

Antibiotic stewardship is another area in which longstanding practices are being reconsidered.

Historically, many cats with urethral obstruction were discharged with antibiotics as a precaution. However, current evidence suggests that bacterial urinary tract infections are **uncommon in young to middle-aged cats with FLUTD or urethral obstruction, with a reported incidence of less than 2%.

Routine empirical antibiotic therapy in these patients is therefore increasingly viewed as unnecessary and potentially harmful. Unwarranted antimicrobial use contributes to antimicrobial resistance and can alter normal gastrointestinal flora.

Because urinary tract infections are uncommon in these patients, routine urine cultures may also be unnecessary in otherwise low-risk cats.²

There are, however, important exceptions.

A urine culture should be more strongly considered in patients with risk factors such as:

• Recent urinary catheterization

• Previous perineal urethrostomy (PU) surgery

• Immunosuppression

• Diabetes mellitus

• Advanced age

The incidence of urinary tract infection increases in cats over 10 years of age and in female cats, making culture and antimicrobial therapy more relevant considerations in these populations.

When antibiotics are indicated, culture-based antimicrobial selection is preferred whenever possible.

Prazosin: Does It Really Prevent Reobstruction?

Another commonly debated therapy is prazosin, an alpha-1 adrenergic antagonist used with the goal of decreasing urethral smooth muscle tone.

Historically, the rationale for prazosin centered on the idea that relaxing the urethra could decrease urethral spasm and reduce the likelihood of recurrent obstruction.

The anatomy of the male feline urethra, however, complicates that theory.

Only approximately the proximal one-quarter to one-third of the male feline urethra is composed of smooth muscle. The distal urethra is predominantly skeletal muscle—and this is where the majority of obstructions occur.

Clinical evidence regarding prazosin has also been inconsistent.

Prospective, double-blind trials have found no significant reduction in recurrent urethral obstruction among cats treated with prazosin compared with placebo following an obstructive episode.⁵

A larger observational study went even further, reporting a **higher rate of recurrent urethral obstruction in cats treated with prazosin.**¹

Based on the current literature, evidence supporting routine prazosin administration for prevention of recurrent urethral obstruction remains weak, and its routine use cannot be confidently recommended.

An Evolving Approach to FLUTD and Urethral Obstruction

There isn't always a simple answer when managing feline lower urinary tract disease and urethral obstruction.

The fundamentals remain essential:

• Stabilize the patient

• Relieve the obstruction when present

• Provide appropriate analgesia

• Correct fluid and electrolyte abnormalities

• Closely monitor recovery

But decisions surrounding medications such as NSAIDs, antimicrobials, and prazosin require additional consideration.

As evidence evolves, treatments once considered routine may deserve another look. Thoughtful patient selection, antimicrobial stewardship, awareness of potential renal compromise, and continued evaluation of emerging research can help veterinary teams make informed decisions for each individual patient.

Ultimately, good medicine means remaining willing to reassess our protocols as new evidence becomes available—while keeping patient safety, comfort, and outcomes at the center of every decision.

Emergency & Critical Care at PASE

At Philadelphia Animal Specialty & Emergency (PASE), our Emergency & Critical Care team is available 24 hours a day, 7 days a week, 365 days a year to support pets, their families, and our referring veterinary community.

Cats experiencing a urethral obstruction require prompt veterinary attention. Signs such as repeated unsuccessful attempts to urinate, straining in the litter box, vocalizing, restlessness, vomiting, lethargy, or producing little to no urine should be treated as an emergency.

Our Emergency & Critical Care team provides stabilization, diagnostics, urinary obstruction management, hospitalization, and ongoing monitoring for cats experiencing FLUTD, urethral obstruction, and other urgent or critical conditions.

Referral & Emergency Information

If you have a patient experiencing FLUTD, suspected urethral obstruction, or another emergency or critical care condition, please contact PASE for additional information or to discuss transfer or referral.

Referrals can also be submitted directly through the PASE referral portal.

PASE's Emergency & Critical Care service is available 24 hours a day, 7 days a week, 365 days a year.

Philadelphia Animal Specialty & Emergency (PASE)
2100 Washington Ave.
Philadelphia, PA 19146
267-727-3738